Shopping Cart (0)
My Account

Shopping Cart
SELECTBIO Conferences 3D-Printing and Biofabrication 2020

Aleksandr Ovsianikov's Biography

Aleksandr Ovsianikov, Professor, Head of Research Group 3D Printing and Biofabrication, Technische Universität Wien (TU Wien)

Dr. Ovsianikov is a full Professor and a head of the group “3D Printing and Biofabrication” at the TU Wien (Vienna, Austria). His research is dealing with the use of additive manufacturing technologies for tissue engineering and regenerative medicine. Dr. Ovsianikov has background in laser physics and material processing with femtosecond lasers. A particular focus his current research is establishing multiphoton lithography in the domain of biofabrication for engineering of biomimetic 3D cell culture matrices and realization of novel tissue engineering scaffolds. Dr. Ovsianikov was awarded a prestigious Starting Grant in 2012 and a Consolidator Grant in 2017 from the European Research Council (ERC) for projects aimed at these topics. Together with Prof. Mironov and Prof. Yoo he is an editor of a living book project “3D Printing and Biofabrication” published by Springer in cooperation with Tissue Engineering and Regenerative Medicine International Society (TERMIS).

Aleksandr Ovsianikov Image

High-Definition Bioprinting

Tuesday, 18 August 2020 at 09:00

Add to Calendar ▼2020-08-18 09:00:002020-08-18 10:00:00Europe/LondonHigh-Definition Bioprinting3D-Printing and Biofabrication 2020 in Boston, USABoston,

3D bioprinting and biofabrication are already providing disruptive solutions for tissue engineering and regenerative medicine (TERM). However, the most widespread technologies are based on computer-controlled deposition of cells or assembly of cellular units, and thus cannot achieve spatial resolution better than few tens of micrometres. Lithography-based methods approach the problem from a different direction, by producing 3D structures within cell-containing materials and can therefore overcome this limitation. Among these methods, multiphoton lithography (MPL) is an outstanding one as it can produce features even smaller than a single mammalian cell (down to around 100 nm). Our recent breakthroughs on the material development side enabled the use of MPL for direct fabrication of cell-containing constructs, giving rise to High-Definition Bioprinting. In this contribution the principles of HD Bioprinting, its recent progress of as well as its perspectives for further TERM applications, will be discussed. The presentation is supported by numerous examples.

Add to Calendar ▼2020-08-17 00:00:002020-08-18 00:00:00Europe/London3D-Printing and Biofabrication 20203D-Printing and Biofabrication 2020 in Boston, USABoston,